https://pubmed.ncbi.nlm.nih.gov/34437922/
JAK inhibitors in the treatment of atopic dermatitis
Aug 24, 2021 ... New topical JAK inhibitors include ruxolitinib (JAK1/2) and delgocitinib (pan-JAK). Ruxolitinib cream met all primary and secondary endpoints in ...